Spleen volume was linked with an increased risk of IBD in a Mendelian randomization study. (Scientific Reports) A dual ...

SpringWorks Therapeutics sprung out of Pfizer’s storeroom, when a rare disease advocacy group pushed to keep a program for ...

A new research paper was published in , Volume 16, on February 18, 2025, titled "Robust p53 phenotypes and prospective downstream targets in telomerase-immortalized human cells." ...

Chen, D. and Li, L. (2025) Huge Pelvic GIST Got Good Control after Resistance to Tyrosine Kinase Inhibitors by SIB-IMRT: A ...

The U.S. Food and Drug Administration (FDA) has approved vimseltinib (Romvimza) for adult patients with a rare condition ...

Updated TIDE-A study findings show that maintenance Bavencio with Inlyta treatment interruption is feasible in patients with ...

H. Ma and S. Srivastava are joint first authors of this article. R. Sundar and P. Tan are joint corresponding and senior authors of this article.

Nubeqa plus ADT improved rPFS in mHSPC regardless of disease volume, reducing the risk of radiological progression or death by 46%, per ARANOTE data.

Former “Real Housewives of Beverly Hills” star Teddi Mellencamp revealed Wednesday that she has been diagnosed with multiple brain tumors and is scheduled to undergo surgery to remove two of them.